Delivery Order SPE2DB24D1104-SPE2DB24FXXE8
Award Date
4/24/24
Potential Completion Date
4/25/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,339,361 units of Lidocaine 5% Patch 30s, a pharmaceutical product. The $1,700.37 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 22, 2024. The award is not associated with a set-aside program. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $1,315.20 for the supply of 4,564,360,453 units of Lidocaine 5% Patch 30s. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the delivery of these pharmaceutical products by April 23, 2024. This contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,895,961 units of Lidocaine 5% Patch 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,077.30 and an ultimate completion date of June 14, 2024. It is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of 4,564,097,616 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,604.39 firm fixed price delivery order has a completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,911,136 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $6,476.85, has a completion date of June 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA)...
This federal contract award, valued at $8,622.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,286,429 units of Lidocaine 5% Patch 30S, a pharmaceutical product, with a completion date of April 16, 2024. Amerisourcebergen Drug Corp's Corporate Office Division has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order (DO) valued at $1,553.37 for the supply of 4,565,089,492 units of Lidocaine 5% Patch 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen, a major pharmaceutical distribution company, without the use of a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4,564,535,197 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award is for the delivery of 4,561,864,810 units of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The $6,304.52 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 18, 2023. The order has an ultimate completion date of August 21, 2023 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $3,877.89 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,454,933 units of Lidocaine 5% Patch 30s, with a period of performance ending on August 15, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is in place through December 2025....